T0	Outcomes 175 191	patient outcomes
T1	Outcomes 388 410	genome-wide expression
T2	Outcomes 939 967	in progression-free survival
T3	Outcomes 1046 1069	of PTK2 gene expression
T4	Outcomes 1125 1180	PTK2 inhibition blunted R-dependent cell death in vitro
T5	Outcomes 1250 1275	increased PTK2 expression